Edesa Biotech, Inc. (EDSA) financial statements (2022 and earlier)

Company profile

Business Address 100 SPY COURT
MARKHAM, ON L3R 5H6
State of Incorp. BC
Fiscal Year End September 30
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2021
TTM
9/30/2021
9/30/2020
9/30/2018
9/30/2017
9/30/2016
9/30/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments687107119
Cash and cash equivalents6874574
Short-term investments   6245
Receivables3300000
Inventory, net of allowances, customer advances and progress billings   0001
Inventory   0001
Prepaid expense   0000
Other undisclosed current assets111    
Total current assets:101281171210
Noncurrent Assets
Operating lease, right-of-use asset000
Property, plant and equipment0001111
Long-term investments and receivables   000 
Long-term investments   000 
Intangible assets, net (including goodwill)222    
Intangible assets, net (excluding goodwill)222    
Deposits noncurrent assets   0000
Total noncurrent assets:2231111
TOTAL ASSETS:1215111281310
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:2110011
Other undisclosed accounts payable and accrued liabilities2110011
Debt  0    
Deferred revenue and credits  0
Other undisclosed current liabilities00    2
Total current liabilities:2120012
Noncurrent Liabilities
Long-term debt and lease obligation 00    
Operating lease, liability 00
Liabilities, other than long-term debt000    
Accounts payable and accrued liabilities000    
Total noncurrent liabilities:000    
Total liabilities:2220012
Stockholders' equity
Stockholders' equity attributable to parent, including:11137117128
Common stock36351957484738
Additional paid in capital552    
Accumulated other comprehensive loss(0)(0)(0)    
Accumulated deficit(31)(26)(13)(50)(45)(40)(35)
Other undisclosed stockholders' equity attributable to parent   5455
Other undisclosed stockholders' equity  2    
Total stockholders' equity:11139117128
TOTAL LIABILITIES AND EQUITY:1215111281310

Income statement (P&L) ($ in millions)

12/31/2021
TTM
9/30/2021
9/30/2020
9/30/2018
9/30/2017
9/30/2016
9/30/2015
Revenues31000011
Revenue, net011
Operating lease, lease income 10 
Other income1      
Cost of revenue(0)(0)(0)(0)(0)(0)(1)
Cost of goods and services sold      (1)
Deferred sales inducement cost, amortization expense(0)(0)     
Other cost of operating revenue   (0)(0)(0)(0)
Gross profit:3100(0)(0)1(0)
Operating expenses(26)(24)(7)(5)(5)(6)(5)
Other undisclosed operating income (loss)(3)(10)0000 
Operating loss:(26)(24)(6)(5)(5)(5)(5)
Nonoperating income (expense)1810000(0)2
Investment income, nonoperating0 00000
Foreign currency transaction gain (loss), before tax0 (0)(0)00(1)
Other undisclosed income from continuing operations before equity method investments, income taxes      1
Loss from continuing operations before income taxes:(8)(13)(6)(5)(5)(5)(3)
Income tax expense(0)(0)(0)(0)(0)(0)(0)
Net loss:(8)(13)(6)(5)(5)(5)(3)
Other undisclosed net income (loss) attributable to parent(7)0     
Net loss available to common stockholders, diluted:(15)(13)(6)(5)(5)(5)(3)

Comprehensive Income ($ in millions)

12/31/2021
TTM
9/30/2021
9/30/2020
9/30/2018
9/30/2017
9/30/2016
9/30/2015
Net loss:(8)(13)(6)(5)(5)(5)(3)
Other comprehensive loss (1)     
Other undisclosed comprehensive loss(1)      
Comprehensive loss:(9)(14)(6)(5)(5)(5)(3)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(6)10    
Comprehensive loss, net of tax, attributable to parent:(15)(13)(6)(5)(5)(5)(3)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: